LeMaitre Q3 sales $61.0M (+11%), EPS $0.75 (+54%); raises FY guidance

LEMAITRE VASCULAR INC

2025-Q3 EPS reported $1.84 revenue$185,149,000

Q3 sales $61.0M (+11% YoY, +12% organic); Grafts +23%, Shunts +18%, Artegraft +33%.
GAAP diluted EPS $0.75 (+54%); adjusted EPS $0.62 (+27%).
Adjusted gross margin 70.8% (up 300 bps) on pricing and manufacturing efficiencies.
Full-year 2025 guidance raised: sales $247-249M, EPS $2.48-2.53 (midpoint +30%).
Quarterly dividend $0.20/share, payable Dec 4 to holders of record Nov 20.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.